- Home
- PSTV vs IMCC Comparison
PSTV vs IMCC Comparison
Compare PSTV & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- IMCC
- Stock Information
- Founded
- PSTV 1996
- IMCC 1980
- Country
- PSTV United States
- IMCC Israel
- Employees
- PSTV N/A
- IMCC N/A
- Industry
- PSTV Medical/Dental Instruments
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- PSTV Health Care
- IMCC Health Care
- Exchange
- PSTV Nasdaq
- IMCC Nasdaq
- Market Cap
- PSTV 7.1M
- IMCC 7.5M
- IPO Year
- PSTV N/A
- IMCC N/A
- Fundamental
- Price
- PSTV $1.20
- IMCC $2.16
- Analyst Decision
- PSTV Strong Buy
- IMCC
- Analyst Count
- PSTV 2
- IMCC 0
- Target Price
- PSTV $13.50
- IMCC N/A
- AVG Volume (30 Days)
- PSTV 33.2K
- IMCC 11.3K
- Earning Date
- PSTV 03-04-2025
- IMCC 03-27-2025
- Dividend Yield
- PSTV N/A
- IMCC N/A
- EPS Growth
- PSTV N/A
- IMCC N/A
- EPS
- PSTV N/A
- IMCC N/A
- Revenue
- PSTV $5,725,000.00
- IMCC $38,042,859.00
- Revenue This Year
- PSTV $32.12
- IMCC $22.59
- Revenue Next Year
- PSTV N/A
- IMCC $32.86
- P/E Ratio
- PSTV N/A
- IMCC N/A
- Revenue Growth
- PSTV 52.63
- IMCC N/A
- 52 Week Low
- PSTV $0.93
- IMCC $1.61
- 52 Week High
- PSTV $2.67
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- PSTV 48.71
- IMCC 44.61
- Support Level
- PSTV $1.18
- IMCC $2.11
- Resistance Level
- PSTV $1.30
- IMCC $2.33
- Average True Range (ATR)
- PSTV 0.09
- IMCC 0.16
- MACD
- PSTV -0.00
- IMCC 0.00
- Stochastic Oscillator
- PSTV 45.42
- IMCC 20.00
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.